Search research articles
Contact Us
Filters
Showing results (301-310 of 676) with videos related to
Page
of 68
Sort By:
Blood
|
February 27, 2001
The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts
B D Smolich, H A Yuen, K A West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2004
The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies
Zhiqing Wang, Yana Zhang, Arabinda Mandal, et al.
BMJ Open
|
May 8, 2019
Investigating the feasibility of a patient feedback tool to improve safety in Australian primary care: a study protocol
Andrea L Hernan, Kate Kloot, Sally J Giles, et al.
Cancer Biology & Therapy
|
April 13, 2019
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
Ilyas Sahin, Aditya Eturi, Andre De Souza, et al.
BMJ Open
|
June 23, 2020
Patient feedback for safety improvement in primary care: results from a feasibility study
Andrea L Hernan, Sally J Giles, Hannah Beks, et al.
British Journal of Haematology
|
October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
A P Jewell, C P Worman, P M Lydyard, et al.
British Journal of Haematology
|
February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL
A P Jewell, K L Yong, C P Worman, et al.
British Journal of Haematology
|
April 1, 1990
Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response
W C de Mel, A V Hoffbrand, F J Giles, et al.
Leukemia & Lymphoma
|
June 7, 2006
Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature
Karen W L Yee, Sharon R Hymes, Lior Heller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2015
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
Lijie Zhai, Stefani Spranger, David C Binder, et al.
Page
of 68
Search research articles
Search
Showing results (301-310 of 676) with videos related to
Sort By:
Page
of 68
Blood
|
February 27, 2001
The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts
B D Smolich, H A Yuen, K A West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2004
The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies
Zhiqing Wang, Yana Zhang, Arabinda Mandal, et al.
BMJ Open
|
May 8, 2019
Investigating the feasibility of a patient feedback tool to improve safety in Australian primary care: a study protocol
Andrea L Hernan, Kate Kloot, Sally J Giles, et al.
Cancer Biology & Therapy
|
April 13, 2019
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
Ilyas Sahin, Aditya Eturi, Andre De Souza, et al.
BMJ Open
|
June 23, 2020
Patient feedback for safety improvement in primary care: results from a feasibility study
Andrea L Hernan, Sally J Giles, Hannah Beks, et al.
British Journal of Haematology
|
October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
A P Jewell, C P Worman, P M Lydyard, et al.
British Journal of Haematology
|
February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL
A P Jewell, K L Yong, C P Worman, et al.
British Journal of Haematology
|
April 1, 1990
Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response
W C de Mel, A V Hoffbrand, F J Giles, et al.
Leukemia & Lymphoma
|
June 7, 2006
Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature
Karen W L Yee, Sharon R Hymes, Lior Heller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2015
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
Lijie Zhai, Stefani Spranger, David C Binder, et al.
Page
of 68